|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/32 | |||
| C07K 16/30 | |||
| A61K 35/14 | |||
| A61P 35/02 |
| (11) | Number of the document | 1666500 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04028473.9 |
| Date of filing the European patent application | 2004-12-01 | |
| (97) | Date of publication of the European application | 2006-06-07 |
| (45) | Date of publication and mention of the grant of the patent | 2011-09-21 |
| (46) | Date of publication of the claims translation |
| (72) |
Lindhofer, Horst, Dr., DE
Morecki, Shoshana, IL
Slavin, Shimon, IL
|
| (73) |
TRION PHARMA GMBH,
Frankfurter Ring 193a, 80807 München,
DE
|
| (54) | Use of trifunctionel antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy |
| Use of trifunctionel antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy |